Showing results (741-750 of 779) with videos related to

Sort By:
Pageof 78
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 8, 2025
Clinical Outcomes According to the Extent of Atherosclerotic Disease in Female Patients Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the WIN-TAVI RegistryBenjamin Bay, Mauro Gitto, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|September 24, 2016
Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) CollaborationGennaro Giustino, Ioannis Mastoris, Usman Baber, et al.
JACC. Cardiovascular Interventions|October 25, 2023
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary InterventionDominick J Angiolillo, Davide Cao, Samantha Sartori, et al.
Circulation. Cardiovascular Interventions|July 11, 2019
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsUsman Baber, Giulio G Stefanini, Gennaro Giustino, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 23, 2019
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trialDavid Power, Ulrich Schäfer, Paul Guedeney, et al.
Lancet (London, England)|September 3, 2024
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trialsMarco Valgimigli, Sung-Jin Hong, Felice Gragnano, et al.
JACC. Cardiovascular Interventions|January 6, 2018
Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES InitiativeJaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|January 15, 2016
Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled TrialsUsman Baber, Gennaro Giustino, Samantha Sartori, et al.
The American Journal of Cardiology|July 16, 2015
Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsGennaro Giustino, Usman Baber, Giulio Giuseppe Stefanini, et al.
The New England Journal of Medicine|November 17, 2019
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve ReplacementGeorge D Dangas, Jan G P Tijssen, Jochen Wöhrle, et al.
Pageof 78